View all cases
UPC CFI 51/2025
Jan 23, 2025·EP3167888 Unitary patent · TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT
- Case details
- StatusCase ClosedActionGenericCategoryGeneric
- Parties
- Division
- Hamburg LD
- Technology
- ChemistryBiotechnology · Pharmaceuticals
- Language
- English
- EPO Opposition
- Samsung Bioepis NL B.V.Withdrawn2024-05-02
- Amgen Technology (Ireland) Unlimited CompanyWithdrawn2024-10-28
- Salute HC Ilaç Pazarlama A.S.Admissible2025-01-31
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Hamburg LD | Locked |
| Judge Sabine Klepsch | Locked |
| Judge Alima Zana | Locked |
| Judge Stefan Schilling | Locked |
| Judge Rudi Goedeweeck | Locked |
At the UPC: Samsung Group (57 cases)·AstraZeneca Group (13 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 6 other proceedings
UPC CoA 744/2025·UPC CFI 674/2025·UPC CFI 40/2025·UPC APP 43786/2024·UPC CoA 402/2024 and 1 more
3 other defendants litigating the same or a related patent
Start a free trial to see how each one ended.
More cases: Hamburg LD·2025
Documents
Show all 22 documents| Document title | Date | Public |
|---|---|---|
| Case closed | 2026-05-07 | Not public |
| Receipt | 2025-07-23 | Not public |
| 20250723_Alexion_vs_SB12_Request_for_Confidentiality_R_262.2_UPC_CFI_51_2025 | 2025-07-23 | Not public |
| 20250314_Alexion_vs_SB12_EP888_Comment_defendant_re_cost_decision.print-to-pdf_Redacted | 2025-07-23 | Not public |
| Exhibit_S_S_03 | 2025-07-23 | Not public |
| Exhibit_S_S_02 | 2025-07-23 | Not public |
| Exhibit_S_S_01 | 2025-07-23 | Not public |
| 20250120_SB12_UPC_Alexion_vs_SB_EP888-request_for_cost_recovery_Redacted | 2025-07-23 | Not public |
| Exhibit_S_S_04 | 2025-07-23 | Not public |
| Formal response to the Order of the Court | 2025-03-14 | Not public |